Health-related quality of life in ADHD: a pooled analysis of gender differences in five atomoxetine trials

Attention-deficit/hyperactivity disorder (ADHD) is associated with considerable impairment in health-related quality of life (HR-QoL). Atomoxetine has been found to improve HR-QoL in both children and adolescents. However, there is scarcity of data on gender differences in treatment responses to ADH...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Wehmeier, Peter M. (VerfasserIn) , Schacht, Alexander (VerfasserIn) , Escobar, Rodrigo (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 21 January 2012
In: ADHD Attention Deficit and Hyperactivity Disorders
Year: 2012, Jahrgang: 4, Heft: 1, Pages: 25-35
ISSN:1866-6647
DOI:10.1007/s12402-011-0070-2
Online-Zugang:Verlag, Volltext: https://doi.org/10.1007/s12402-011-0070-2
Volltext
Verfasserangaben:Peter M. Wehmeier, Alexander Schacht, Rodrigo Escobar, Amaia Hervas, Ruth Dickson

MARC

LEADER 00000caa a2200000 c 4500
001 1663718156
003 DE-627
005 20220816142611.0
007 cr uuu---uuuuu
008 190429s2012 xx |||||o 00| ||eng c
024 7 |a 10.1007/s12402-011-0070-2  |2 doi 
035 |a (DE-627)1663718156 
035 |a (DE-599)KXP1663718156 
035 |a (OCoLC)1341211809 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Wehmeier, Peter M.  |d 1963-  |e VerfasserIn  |0 (DE-588)112354939  |0 (DE-627)503816221  |0 (DE-576)289728894  |4 aut 
245 1 0 |a Health-related quality of life in ADHD  |b a pooled analysis of gender differences in five atomoxetine trials  |c Peter M. Wehmeier, Alexander Schacht, Rodrigo Escobar, Amaia Hervas, Ruth Dickson 
264 1 |c 21 January 2012 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 29.04.2019 
520 |a Attention-deficit/hyperactivity disorder (ADHD) is associated with considerable impairment in health-related quality of life (HR-QoL). Atomoxetine has been found to improve HR-QoL in both children and adolescents. However, there is scarcity of data on gender differences in treatment responses to ADHD medications. This pooled analysis of five atomoxetine trials aimed to evaluate treatment differences with respect to HR-QoL and ADHD symptoms across genders. Data from 5 clinical atomoxetine trials (4 from Europe and 1 from Canada) with similar inclusion and exclusion criteria and similar durations (8- to 12-week follow-up) were included in the pooled analysis. All studies included the Child Health and Illness Profile—Child Edition (CHIP-CE) Parent Report Form. In addition, correlations between HR-QoL and ADHD core symptoms were compared between girls and boys. Data from 136 girls and 658 boys (mean age: 9.6 and 9.7 years, respectively) were pooled. Boys and girls were similarly impaired at baseline with minor differences in some of the subdomains. Treatment effect of atomoxetine was significant in both groups for the Risk Avoidance domain and its subdomains. No gender effect with both clinical and statistical significance was found for treatment outcome. Correlations between ADHD Rating Scale and CHIP-CE scores were similar in both genders and were generally low at baseline and moderate at endpoint and for the change from baseline to endpoint. Atomoxetine was effective in improving some aspects of HR-QoL in both genders without any significant differences across genders. Correlations between core symptoms of ADHD and HR-QoL were low to moderate in both boys and girls. 
650 4 |a ADHD 
650 4 |a Atomoxetine 
650 4 |a Gender differences 
650 4 |a Quality of life 
700 1 |a Schacht, Alexander  |e VerfasserIn  |0 (DE-588)1181364175  |0 (DE-627)1662665385  |4 aut 
700 1 |a Escobar, Rodrigo  |e VerfasserIn  |0 (DE-588)1181369002  |0 (DE-627)1662668694  |4 aut 
773 0 8 |i Enthalten in  |t ADHD Attention Deficit and Hyperactivity Disorders  |d Wien [u.a.] : Springer, 2009  |g 4(2012), 1, Seite 25-35  |h Online-Ressource  |w (DE-627)595709958  |w (DE-600)2486747-0  |w (DE-576)307016315  |x 1866-6647  |7 nnas  |a Health-related quality of life in ADHD a pooled analysis of gender differences in five atomoxetine trials 
773 1 8 |g volume:4  |g year:2012  |g number:1  |g pages:25-35  |g extent:11  |a Health-related quality of life in ADHD a pooled analysis of gender differences in five atomoxetine trials 
856 4 0 |u https://doi.org/10.1007/s12402-011-0070-2  |x Verlag  |x Resolving-System  |3 Volltext 
951 |a AR 
992 |a 20190429 
993 |a Article 
994 |a 2012 
998 |g 112354939  |a Wehmeier, Peter M.  |m 112354939:Wehmeier, Peter M.  |d 60000  |e 60000PW112354939  |k 0/60000/  |p 1  |x j 
999 |a KXP-PPN1663718156  |e 3453668820 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"roleDisplay":"VerfasserIn","display":"Wehmeier, Peter M.","role":"aut","family":"Wehmeier","given":"Peter M."},{"family":"Schacht","given":"Alexander","display":"Schacht, Alexander","roleDisplay":"VerfasserIn","role":"aut"},{"given":"Rodrigo","family":"Escobar","role":"aut","display":"Escobar, Rodrigo","roleDisplay":"VerfasserIn"}],"title":[{"subtitle":"a pooled analysis of gender differences in five atomoxetine trials","title":"Health-related quality of life in ADHD","title_sort":"Health-related quality of life in ADHD"}],"note":["Gesehen am 29.04.2019"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"recId":"1663718156","name":{"displayForm":["Peter M. Wehmeier, Alexander Schacht, Rodrigo Escobar, Amaia Hervas, Ruth Dickson"]},"origin":[{"dateIssuedKey":"2012","dateIssuedDisp":"21 January 2012"}],"id":{"doi":["10.1007/s12402-011-0070-2"],"eki":["1663718156"]},"physDesc":[{"extent":"11 S."}],"relHost":[{"title":[{"title_sort":"ADHD Attention Deficit and Hyperactivity Disorders","title":"ADHD Attention Deficit and Hyperactivity Disorders"}],"origin":[{"publisherPlace":"Wien [u.a.]","dateIssuedDisp":"2009-2019","publisher":"Springer","dateIssuedKey":"2009"}],"id":{"zdb":["2486747-0"],"eki":["595709958"],"issn":["1866-6647"]},"disp":"Health-related quality of life in ADHD a pooled analysis of gender differences in five atomoxetine trialsADHD Attention Deficit and Hyperactivity Disorders","type":{"media":"Online-Ressource","bibl":"periodical"},"physDesc":[{"extent":"Online-Ressource"}],"recId":"595709958","language":["eng"],"pubHistory":["1.2009 - 11.2019; damit Ersch. eingest."],"part":{"year":"2012","pages":"25-35","issue":"1","volume":"4","text":"4(2012), 1, Seite 25-35","extent":"11"}}]} 
SRT |a WEHMEIERPEHEALTHRELA2120